|
|
Educational Strategies to Prevent
Prehospital Delay in Patients at High
Risk for Acute Myocardial Infarction
Suzanne K. White, MN, RN, FAAN, FCCM, CNAA
Vice President, Cardiovascular Services/Clinical Affairs
Saint Joseph's Hospital of Atlanta
Atlanta, GA
Quick Overview
Acute Myocardial Infarction
Education Regarding Symptoms
Actions Taken if Symptoms Occur
Patient Advisory Form
National Heart Atttack Alert Program Coordinating
Committee...
Patient Representatives
NHLBI Staff
Support Contract
Many effective therapies are now available for patients
with acute cardiac ischemia, acute myocardial infarction (AMI), potentially
fatal arrhythmias, and cardiogenic shock if they seek and receive care expeditiously.
However, delays in accessing and receiving care are a continuing problem,
threatening the effectiveness of available treatments. Patients with previously
diagnosed coronary heart disease (CHD), including a previous AMI, have the
same or greater delay times as those without prior AMI or CHD. Because of
the high-risk status of these patients, combined with the problem of delay
in seeking care, a Working Group of the National Heart Attack Alert Program
(NHAAP), National Heart, Lung, and Blood Institute, of the National Institutes
of Health advises physicians and other healthcare providers of their important
role in reducing treatment delay in these patients. The Working Group recommends
that primary care clinicians in the office and in inpatient settings provide
these patients and their family members or significant others contingency
counseling about actions to take in response to symptoms of an AMI/acute
cardiac ischemia.
Ideally, education regarding the symptoms and signs
of AMI and the need to seek treatment promptly should be directed at all
individuals and is a long-term goal of the NHAAP. However, in order to focus
resources on individuals who might derive the greatest potential benefit,
educational and counseling interventions should be aimed at reducing patient
delay for those individuals who are at high risk for a future AMI. Based
on health interviews conducted in 1992, approximately 7 million Americans
have CHD, about 3 million have cerebrovascular disease, and about 2 million
have peripheral vascular disease. (1) Patients with established CHD, clinical
atherosclerotic disease of the aorta or peripheral arteries, or clinical
cerebrovascular disease are at high risk for subsequent AMI or CHD death.
(2-4) The risk for subsequent AMI and death in patients with established
CHD (or other atherosclerotic disease) is fivefold to sevenfold higher than
for the general population. (2) It is particularly important to focus within
this high-risk patient group on women, African Americans, and the elderly;
these populations have longer reported delays in seeking care in response
to AMI symptoms.
Education should be targeted at patients with established CHD or clinical
atherosclerotic disease, including their family members/significant others.
Patients with established CHD include those with a history of AMI, angina,
coronary artery bypass surgery, or angioplasty. In addition, patients with
previously diagnosed peripheral arterial disease (eg, patients with claudication
or an abdominal aortic aneurysm) should be targeted. Substantial carotid
atherosclerosis is documented by cerebral symptoms (eg, patients with transient
ischemic attacks or stroke) and demonstration of significant atherosclerosis
on ultrasound or angiogram. (5)
The content of the recommended educational message includes three essential
components: information, emotional issues, and social factors. Patients
should be given information about the typical symptoms of AMI and the action
steps to take if they experience any of those symptoms. Although the presentation
of AMI can be atypical, (6,7) the majority of patients will present with
chest pain/discomfort, left arm pain/heaviness, shortness of breath, or
a feeling of dread. (8) The differences in presentation profiles, if any,
between patients with a CHD history and those presenting for the first time
are not well delineated.
Providers should keep in mind that presenting symptoms of AMI in the elderly
may be vague. Older patients more often have a history of hypertension,
congestive heart failure, and MI, as well as longer delay times, than younger
patients. Among 1,848 patients more than 65 years of age from the Myocardial
Infarction Triage and Intervention (MITI) trial, a relatively high proportion
of these elderly individuals had no chest pain when first evaluated in the
hospital, and fewer elderly patients had ST elevation on the initial electrocardiogram
(ECG). (9)
Clark et al (10) found that minority patients have lower levels of symptom
recognition and belief in treatability. According to Raczynski et al, (11)
African-American patients admitted for CHD report fewer painful symptoms
and are more likely to attribute symptoms to noncardiac origins (eg, gastrointestinal
tract).
Since many patients believe that an AMI is accompanied by sudden, crushing
chest pain and unconsciousness, (12) patients should be told that the symptoms
may come on gradually or may be intermittent. The educational message should
be adapted to an individual patient's history of symptom presentation; for
example, the physician can emphasize jaw discomfort if this symptom occurred
in the past as part of the patient's ischemic presentation. However, all
of the more frequent presenting symptoms should be addressed since a second
heart attack may not manifest itself exactly the same way as the first (something
patients should also be told, even though this has not been well studied).
Patients must be clear about the actions they should
take if AMI symptoms occur. These behaviors include taking nitroglycerin
(if prescribed), taking aspirin, and calling the emergency medical services
(EMS). Advice about medications should be tailored to the needs of individual
patients. The guideline for the use of nitrates for anginal pain published
in the Clinical Practice Guideline, Unstable Angina: Diagnosis and Management,
by the Agency for Health Care Policy and Research Guideline Panel (13) appears
sound. Patients are directed to take one nitroglycerin tablet as soon as
they feel discomfort, take a second tablet if the discomfort does not go
away in 5 minutes, and take a third tablet after 5 more minutes if symptoms
persist. If the medication does not relieve the discomfort in 15 minutes,
they should go to the hospital immediately by activating EMS.
Quick Overview
Acute Myocardial Infarction
Education Regarding Symptoms
Actions Taken if Symptoms Occur
Patient Advisory Form
National Heart Atttack Alert Program Coordinating
Committee...
Patient Representatives
NHLBI Staff
Support Contract
Because of aspirin's demonstrated benefit in the case of an acute ischemic
event, (14) patients should additionally be advised to chew an adult-strength
(325 mg), noncoated aspirin tablet as part of their emergency action plan.
Activation of EMS shortens delay for almost all patients with suspected
AMI (15); therefore, high-risk patients and their families should be told
to call 9-1-1 or their seven-digit emergency number when a patient has symptoms
suggestive of AMI. If a patient lives in a rural area or is a long distance
from the nearest hospital, the healthcare provider should discuss the appropriateness
and merits of alternative plans. Having a family member or friend drive
is not recommended because the person driving the patient cannot render
any patient care and usually cannot communicate with the hospital while
en route. Arrival at the emergency department (ED)/trauma center by private
vehicle has been shown to delay triage and assessment of trauma patients
compared with patients conveyed by EMS. (16) For the AMI patient, prehospital
identification by history or ECG has been shown to decrease time to treatment
in the ED. (17,18)
A sample form for presenting patient information is presented in Figure
1.
Patient Advisory Form
It can be individualized by physicians and other healthcare providers
to include any unusual symptoms a patient may experience suggesting an evolving
AMI, instructions for any special medications such as nitrates, aspirin,
or others (eg, beta blockers) that the patient may need, the EMS phone number
in the community, and the location of the hospital with 24-hour ED service
closest to the patient's home and work. Physicians and other healthcare
providers can suggest that patients keep the form on their refrigerators
or with their other emergency numbers, as well as keep a copy at work. The
selected message regarding symptom constellation and recommended action
steps should also be recorded in the patient's medical record so it can
be reinforced by other healthcare providers in the setting. All instructions
should be entered in the patient's record so other members of the healthcare
team can reinforce them during future visits.
Counseling should address the emotional aspects (eg, fear and denial) that
patients and those around them may experience, as well as barriers that
may be associated with the healthcare delivery system. Because the majority
of patients consult a family member or significant other about their symptoms,
(19,20) the latter should be included in all education and counseling interactions
and have a good understanding of the nature of AMI symptoms and the importance
of calling EMS quickly. Assistance from other healthcare providers (eg,
nurses) should be solicited to initiate, reinforce, and supplement the counseling.
A Patient Advisory Form is offered as an aid to providers in counseling
their high-risk patients about these issues. Other materials and aids should
be considered as well. Physicians' offices and clinics should devise a system
to triage patients rapidly when they call or walk in seeking advice for
possible AMI symptoms. Further research is needed to learn more about effective
counseling strategies, symptom manifestation in high-risk groups, including
women and minorities, and healthcare delivery systems that enhance access
to timely care for CHD patients.
Quick Overview
Acute Myocardial Infarction
Education Regarding Symptoms
Actions Taken if Symptoms Occur
Patient Advisory Form
National Heart Atttack Alert Program Coordinating
Committee...
Patient Representatives
NHLBI Staff
Support Contract
National Heart Attack Alert Program Coordinating
Committee
Working Group on Educational Strategies To Prevent Prehospital
Delay in Patients at High Risk for Acute Myocardial Infarction
Kathleen Dracup, RN, DNSc (Chair)
Professor and LW Hassenplug Chair of Nursing
School of Nursing
University of California at Los Angeles
Los Angeles, CA
Angelo A. Alonzo, PhD
Associate Professor of Sociology
The Ohio State University
Columbus, OH
James M. Atkins, MD, FACC
Medical Director, Dallas Emergency Medical Services
Professor of Medicine
Department of Internal Medicine
University of Texas Southwestern Medical
Center at Dallas
Dallas, TX
Nancy M. Bennett, MD, MS
Assistant Professor of Medicine
Assistant Professor of Community and Preventive Medicine
University of Rochester School of Medicine and Dentistry
Deputy Health Director
Monroe County Health Department
Rochester, NY
Allan Braslow, PhD
President
Braslow and Associates
Alexandria, VA
Luther Clark, MD
Director of Preventive Cardiology
Associate Professor of Clinical Medicine
Department of Medicine
State University of New York Health Science Center
Brooklyn, NY
Mickey Eisenberg, MD, PhD
Professor of Medicine
University of Washington
Emergency Medical Services
University of Washington Medical Center
Seattle, WA
Keith Copelin Ferdinand, MD, FACC
Medical Director
Heartbeats Life Center of New Orleans
Associate Professor, Clinical Pharmacology
College of Pharmacy
Xavier University of New Orleans
New Orleans, LA
Robert Frye, MD, FACC
Chair, Internal Medicine
Professor of Medicine
Cardiovascular Consultant
Mayo Clinic
Rochester, MN
Lee Green, MD, MPH
Assistant Professor
Department of Family Practice
University of Michigan Medical School
Ann Arbor, MI
Martha Hill, PhD, RN
Associate Professor
School of Nursing
Johns Hopkins University
Baltimore, MD
J. Ward Kennedy, MD
Professor of Medicine
University of Washington
Director, Division of Cardiology
University Hospital
Seattle, WA
Eva Kline-Rogers, MS, RN
Clinical Nurse Specialist
Cardiology Department
University of Michigan Medical Center
Ann Arbor, MI
Debra K. Moser, DNSc, RN
Assistant Professor of Nursing
College of Nursing
Ohio State University
Columbus, OH
Joseph P. Ornato, MD, FACC
Professor of Internal Medicine (Cardiology)
Director of Research
Department of Emergency Medicine
Virginia Commonwealth University/Medical College of Virginia
Richmond, VA
Bertram Pitt, MD
Professor of Internal Medicine
Division of Cardiology
University of Michigan Hospital
Ann Arbor, MI
Jane D. Scott, ScD, MSN
Health Scientist Administrator
Center for Medical Effectiveness Research
Agency for Health Care Policy and Research
Rockville, MD
Harry P. Selker, MD, MSPH
Chief, Division of Clinical Care Research
Director, Center for Cardiovascular Health Services Research
New England Medical Center
Associate Professor of Medicine
Tufts University School of Medicine
Boston, MA
Sharon Silva, PhD
Evaluation Associate
Public Policy and Planning
American Red Cross National Headquarters
Washington, DC
William Thies, PhD
Director
Emergency Cardiac Care Programs
American Heart Association
Dallas, TX
W. Douglas Weaver, MD
Professor of Medicine
Director, Cardiovascular Critical Care
University of Washington
Seattle, WA
Nanette K. Wenger, MD
Professor of Medicine (Cardiology)
Emory University School of Medicine
Director, Cardiac Clinics
Grady Memorial Hospital
Atlanta, GA
Suzanne K. White, MN, RN, FAAN, FCCM, CNAA
Vice President, Cardiovascular Services/Clinical Affairs
St. Joseph's Hospital of Atlanta
Atlanta, GA
Quick Overview
Acute Myocardial Infarction
Education Regarding Symptoms
Actions Taken if Symptoms Occur
Patient Advisory Form
National Heart Atttack Alert Program Coordinating
Committee...
Patient Representatives
NHLBI Staff
Support Contract
Patient Representatives
Alan Jung, DDS
Baltimore, MD
Ms. Jane Lynn
Severna Park, MD
NHLBI Staff:
Patrice Desvigne-Nickens, MD
Director, Heart Research Program
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
Mary M. Hand, MSPH, RN
Coordinator, National Heart Attack Alert Program
Office of Prevention, Education, and Control
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
Michael Horan, MD, ScM
Director
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
Denise Simons-Morton, MD, PhD
Medical Officer
Division of Epidemiology and Clinical Applications
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
George Sopko, MD
Medical Officer
Health Scientist Administrator
Division of Heart and Vascular Diseases
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, MD
Support Contract
John C. Bradley, MS
R.O.W. Sciences, Inc.
Rockville, MD
Susan Shero, RN, MS
R.O.W. Sciences, Inc.
Rockville, MD
Acknowledgement: Mary Pat Larsen, King County Department of Emergency Medical
Services, Seattle, WA, for statistical support.
References
1. National Heart, Lung, and Blood Institute. Morbidity and Mortality.
Chartbook on Cardiovascular, Lung, and Blood Diseases. Public Health Service,
National Institutes of Health, National Heart, Lung, and Blood Institute.
May 1994.
2. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period
of 10 years in patients with peripheral arterial disease. N Engl J Med.
1992;326:381-386.
3. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular
disease in relation to cholesterol level among men with and without preexisting
cardiovascular disease. N Engl J Med. 1990;322:1700-1707.
4. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology
and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245-1249.
5. National Cholesterol Education Program. Second Report of the Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol
in Adults (Adult Treatment Panel II). National Institutes of Health. National
Heart, Lung, and Blood Institute. NIH Publication No. 93-3095. September
1993.
6. Margolis JR, Kannel WS, Feinleib M, et al. Clinical features of
unrecognized myocardial infarction - silent and symptomatic. Eighteen-year
follow-up: the Framingham study. Am J Cardiol. 1973;32:1-7.
7. Uretsky BF, Farquhar DS, Berezin AF, et al. Symptomatic myocardial
infarction without chest pain: prevalence and clinical course. Am J Cardiol.
1977;40:498-503.
8. Gillum RF, Fortmann SP, Prineas RJ, et al. International diagnostic
criteria for acute myocardial infarction and stroke. Am Heart J. 1984;108:150-158.
9. Weaver WD, Litwin PE, Martin JS, et al. (MITI Project Group). Effect
of age on use of thrombolytic therapy and mortality in acute myocardial
infarction. J Am Coll Cardiol. 1991;18:657-662.
10. Clark LT, Bellam SV, Shah AH, et al. Analysis of prehospital delay among
inner-city patients with symptoms of myocardial infarction: implications
for therapeutic intervention. J Natl Med Assoc. 1992;84:931-937.
11. Raczynski JM, Taylor H, Cutter G, et al. Diagnoses, symptoms, and attribution
of symptoms among black and white inpatients admitted for coronary heart
disease. Am J Public Health. 1994;84:951-956.
12. Johnson JA, King KB. The influence of expectations about symptoms on
delay in seeking treatment during myocardial infarction. Am J Crit Care.
1995;4:29-35.
13. Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis
and Management. Clinical Practice Guideline Number 10. AHCPR Publication
No. 94-0602. Rockville, MD: Agency for Health Care Policy and Research
and the National Heart, Lung, and Blood Institute, Public Health Service,
U.S. Department of Health and Human Services. March 1994.
14. Second International Study of Infarct Survival (ISIS-2) Steering Committee.
Intravenous streptokinase given within 0-4 hours of onset of myocardial
infarction reduced mortality in ISIS-2. Lancet. 1987;1:502. Letter.
15. Weaver WD, Kennedy JW. Myocardial infarction - thrombolytic therapy
in the prehospital setting. In: Fuster V, Verstraete M, eds. Thrombosis
in Cardiovascular Disorders. Philadelphia, PA: WB Saunders Co; 1992:275-287.
16. Hammond J, Gomez GA, Fine E, et al. The non-use of 9-1-1. Private transport
of trauma patients to a trauma center. Prehospital Disaster Med. 1993;8:35-38.
17. Kereiakes DJ, Weaver D, Anderson JL, et al. Time delays in the diagnosis
and treatment of acute myocardial infarction: a tale of eight cities. Report
from the Pre-hospital Study Group and the Cincinnati Heart Project. Am
Heart J. 1990;120:773-780.
18. Weaver WD, Cerqueira M, Hallstrom AP, et al, for the Myocardial Infarction
Triage and Intervention Project Group. Prehospital-initiated vs hospital-initiated
thrombolytic therapy. The Myocardial Infarction Triage and Intervention
trial. JAMA. 1993;270:1211-1216.
19. Alonzo AA. The impact of the family and lay others on care-seeking during
life-threatening episodes of suspected coronary artery disease. Soc Sci
Med. 1986;22:1297-1311.
20. Reilly A, Dracup K, Dattolo J. Factors influencing prehospital delay
in patients experiencing chest pain. Am J Crit Care. 1994;3:300-306.
Return to Index of Articles for Clinician;
Volume 14.4
Home | What's New | What is EHAC? | Abstracts & Articles
Reader's Digest | Contact Us | Search
Tips for Searching
www.ehac.org.
Site by AllSoldOut Internet Solutions
Visit the Clinical Information EHAC site at www.chestpaincenters.org.
Copyright © 1996-2001
by St. Agnes Healthcare. All Rights Reserved.
|
|